🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How do you consider all potential risk factors and treatment options for a patient with FSGS? We need a better way than just trying steroids to see if it works Kate Robson Roger Rodby Bill Whittier #GlomConHawaii

Final day at #GlomConHawaii Dr Carla Nester presenting on C3G and TMA #nephtwitter GlomCon Many faces of TMA

Not all TMA is complement- a case for specificity #GlomConHawaii GlomCon 🌟TTP 🌟Anti VEGF agents 🌟CNI 🌟G6PD deficiency

GlomCon Sayna Norouzi, MD, FASN Dr Nester clarifies the terminology of 🌟C3G 🌟C3 dominant 🌟C3GN #GlomConHawaii GlomCon Portugal GlomCon

Invitation to apply for the GlomCon virtual fellowship by Fellowship director Kate Robson at #GlomConHawaii Wonderful opportunity for academia, mentorship, networking and friendship. #Podocin #Nephtwitter Closing date August 15th glomcon.org/fellowship

K/L FLC ratio unlocked Roger Rodby #GlomConHawaii GlomCon

❤️ GlomCon seminar and fellowship directors unite ❤️ with spectacular Dia Waguespack #kindredspirits #lefthanders #GlomConHawaii

Glommunication, glomquiry and glomtroversy flowing naturally with Rush Nephrology duo Roger Rodby Bill Whittier great supporters of GlomCon fellowship - for once not in my PJs over Zoom! 💻 🌒 🌍 😆 #GlomConHawaii

Proliferative glomerulonephritis with monoclonal gammopathy, organised microtubular deposits on EM 🤩 ‘Streaming bundles’ of immunotactoid Jean Hou, MD #GlomConHawaii @Glomcon

‘This conference has been a unique experience and a tremendous success’ Richard J. Glassock remarking on the vibrant collegiate discussion at #GlomconHawaii #olddognewtricks 😊 GlomCon

#GlomConHawaii wasn’t just a conference, it was a family reunion for nephrology enthusiasts! 🤝🔬 Building lifelong friendships, forging powerful connections, and sharing groundbreaking ideas to advance our field. Who’s ready to make a difference together? #GlomCon #NephTwitter

A highlight to share #GlomConHawaii with the fabulous Dilushi Wijayaratne Invaluable Podocin GlomCon Fellowship instructor, nephrologist 🇱🇰, researcher, PhD candidate and friend 🌟🙌🏼🏝️🌍🙏🏼

🤔Considering applying for the GlomCon Fellowship but not quite sure? We’ve got you covered! 🗣️Let’s hear from previous fellows: 👩🏽‍🎓🧑🏽‍🎓Dear former Fellow: If you had to describe your Fellowship experience in just 3 words, what would they be? glomcon.org/fellowship 👇🏽

I will go first: 💥Transformative 💥Quality 💥Family It all started as a fellowship and blossomed into a wonderful family.

Sol Carriazo, Neph. Sahar Koubar Haresh Selvaskandan Nasim Wiegley, MD, FASN Joana Gameiro Stephanie Torres M.D. Diana Mahbod, MD, CPE, FASN, FNKF Jorge Gaytan Arocha Isabel Arvind singh Paul E. Hanna, MD MSc For me: ✅ networking ✅ friendship ✅ knowledge You’re next: Jorge Gaytan Arocha MaFer Zavala Lucia Facal Kelly Haughton, MD Nihal👩‍⚕️ Izabela Zakrocka

Important new study from FAIRVASC Vasculitis_Lund Vasculitis_Luebeck Mark Little and many others re-defining AAV subtypes by using close to 4,000 patients with GPA and MPA! The Lancet Rheumatology

Membranous nephropathy (MN) can occur in the transplant kidney as recurrent or de novo MN. Recurrent MN is often PLA2R+ De novo MN is PLA2R-negative & often associated with antibody-mediated rejection. The target antigen is unknown FAT1 is the antigen! kidney-international.org/article/S0085-…

The Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) from KDIGO is out for public review ‼️ #KDIGOIgAN #Nephpearls 📌 Submit comments by Sept 30 🗓️ 👉 kdigo.org/guidelines/iga…

The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is available for public review through Monday, September 30. You can download the public review draft and share comments via the feedback survey on the KDIGO

Brilliant session at today’s GlomCon VF with Suceena Alexander providing state-of-art insights on the pathogenesis of IgAN as well as snapshot of the GraceIgAN prospective study. 2 solid presentations by our fellows Maria simanjuntak and Anita Miranda